PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0018799|heart disease |
| Sentences | 28 |
| PubMedID- 22131755 | [26] furthermore, insulin-resistant patients, with and without type 2 diabetes, are at an increased risk for developing metabolic syndrome, a major cause of heart disease, hypertension and dyslipidemia. |
| PubMedID- 26274823 | The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study. |
| PubMedID- 21151616 | Unlike class i and iia hdacs, class iii hdacs play an important role in regulating oxidative stress in heart diseases with metabolic syndromes. |
| PubMedID- 23091851 | Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism. |
| PubMedID- 26137453 | There has been one case report of eec syndrome associated with congenital heart disease (ventricular septal defect with aortic regurgitation) (17). |
| PubMedID- 22548293 | Metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat). |
| PubMedID- 24793349 | Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians. |
| PubMedID- 24174878 | After an additional follow-up period of 4.9 years, coronary artery calcium progression was able to predict coronary heart disease events in patients with metabolic syndrome and without type 2 diabetes, as well as in those with type 2 diabetes. |
| PubMedID- 22355990 | Objective: to evaluate the frequency of metabolic syndrome in patients with ischaemic heart disease. |
| PubMedID- 26413101 | Genetic syndromes associated with congenital heart disease. |
| PubMedID- 21186101 | This study evaluates the association of incident clinical coronary heart disease with metabolic syndrome and each of its individual defining components in a sample of spanish working males. |
| PubMedID- 22906266 | Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status. |
| PubMedID- 19969373 | Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the heart and soul study. |
| PubMedID- 23782575 | The presence of a recognized genetic syndrome associated with congenital heart disease (for example digeorge, noonan’s or williams’ syndromes), or of developmental delay, were exclusion criteria. |
| PubMedID- 23479983 | Aim: to identify the factors most substantially influencing the quality of life (ql) in patients with coronary heart disease (chd) associated with metabolic syndrome (ms), by using the principal component method. |
| PubMedID- 23819342 | [comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. |
| PubMedID- 21139493 | Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome. |
| PubMedID- 25018941 | The increased risk of coronary heart disease associated with nephrotic syndrome. |
| PubMedID- 20940070 | Objective: we examined the risk of cardiovascular disease, stroke, ischaemic heart disease, and diabetes with the metabolic syndrome according to the new harmonised definition and its components using a national longitudinal data set from an asian population. |
| PubMedID- 22780328 | Introduction: excessive abdominal obesity along with other risk factors results in the metabolic syndrome, which can lead to heart disease, type-2 diabetes, and death. |
| PubMedID- 21636030 | We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome. |
| PubMedID- 19935427 | The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. |
| PubMedID- 20826918 | The aim of the present study was to determine the associations between platelet morphology markers and hemoglobin a1c (hba(1c)), fasting glucose (fg), hypertension and coronary heart disease (chd) in patients with myelodysplastic syndromes (mds) and dm, in patients with dm and in controls. |
| PubMedID- 23251156 | The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin [26, 27]. |
| PubMedID- 22323895 | A widely held view is that large hdl2 particles are atheroprotective.27 the role of hdl3 particles in preventing atherogenesis on the other hand is less clear.27,28 some studies have reported that hdl3 is significantly associated with coronary heart disease, particularly in patients with metabolic syndrome because small hdl particles coincide with low hdl cholesterol levels and can be functionally compromised in patients with metabolic syndrome.4,16 other studies associate the small hdl3 particle with atheroprotective functions, including an ability to mature into larger hdl2 and promote reverse cholesterol transport, and to antagonize and inhibit inflammation and oxidation within blood vessel walls.29–31 discordance in these data may reflect the complex relationships between hdl subclasses, methods of fractionation, physiological versus pathological conditions (such as metabolic diseases or presence of coronary artery disease), or treatment effects with different lipid-modifying drugs. |
| PubMedID- 22323866 | Visceral fat is independently related to morbidity and mortality of the coronary heart disease and associated with metabolic syndrome, diabetes, and cardiovascular disease. |
| PubMedID- 26401840 | Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study. |
| PubMedID- 21153653 | Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics. |
Page: 1